Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2026-06-27 @ 6:50 AM
Study NCT ID:
NCT04822805
Status:
UNKNOWN
Last Update Posted:
2021-03-30
First Post:
2021-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
Sponsor:
First People's Hospital of Hangzhou
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
H2CH2020M504
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |